Your browser doesn't support javascript.
loading
Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.
Golhen, Klervi; Winskill, Carolyn; Theiler, Martin; Buettcher, Michael; Yeh, Yu-Hsin; Zhang, Nancy; Welzel, Tatjana; Pfister, Marc.
Afiliación
  • Golhen K; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Winskill C; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Theiler M; Pediatric Skin Center, Dermatology Department, University Children's Hospital Zurich, Zurich, Switzerland.
  • Buettcher M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Yeh YH; Pediatric Infectious Diseases Unit, Pediatric Department, Children's Hospital - Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Zhang N; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Welzel T; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Pfister M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Front Med (Lausanne) ; 9: 944208, 2022.
Article en En | MEDLINE | ID: mdl-36226155

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza